D. A. Greene

6.5k citations

64 papers · 4.9k indexed · 2 hit papers · h-index 35

Physiology top 0.5%
Neurology top 0.5%
Cell Biology top 1%
Endocrinology, Diabetes and Metabolism top 1%
Molecular Biology top 10%

Co-authors: S. A. Lattimer Anders A. F. Sima Martin Stevens Eva L. Feldman Marc B. Brown N. Canal P. K. Thomas A. I. Winegrad
Topics: Pain Mechanisms and Treatments (25 papers)Aldose Reductase and Taurine (19 papers)Biochemical effects in animals (14 papers)
Cited by: Physiology Neurology Clinical Biochemistry
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation Neurology
Partner nations: United States Canada Australia

In The Last Decade

D. A. Greene

64 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy

1994 995 citations Eva L. Feldman, Martin Stevens et al. profile →
Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.

1975 402 citations D. A. Greene et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by D. A. Greene

Since Specialization

Citations

This map shows the geographic impact of D. A. Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. Greene more than expected).

Fields of papers citing papers by D. A. Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. A. Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. Greene. The network helps show where D. A. Greene may publish in the future.

Co-authorship network of co-authors of D. A. Greene

This figure shows the co-authorship network connecting the top 25 collaborators of D. A. Greene. A scholar is included among the top collaborators of D. A. Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. A. Greene. D. A. Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Digital electron microscopic examination of human sural nerve biopsies 2003 ·Journal of the Peripheral Nervous System ·Kelli A. Sullivan,(unknown),(unknown),D. A. Greene	10
2	Sorbitol and myo‐inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance 2000 ·Diabetic Medicine ·G. Sundkvist,Lars B. Dahlin,Håkan Nilsson,(unknown),Folke Lindgärde,I. Rosén,S. A. Lattimer,Anders A. F. Sima,K. Sullivan,D. A. Greene	50
3	Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study 1999 ·Diabetologia ·Irina G. Obrosova,Lamia Fathallah,Hans‐Jochen Lang,D. A. Greene	62
4	Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. 1996 ·Journal of Clinical Investigation ·Anders A. F. Sima,Helen Ristic,Alan Merry,Mikiko Kamijo,S. A. Lattimer,M. J. Stevens,D. A. Greene	78
5	Acetyl-l-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat 1996 ·Metabolism ·M. J. Stevens,S. A. Lattimer,Eva L. Feldman,Edward D. Helton,David S. Millington,A. A. F. Sima,D. A. Greene	61
6	Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells. 1996 ·Journal of Clinical Investigation ·Hiroko Shindo,T. Thomas,Dennis Larkin,Anil Karihaloo,(unknown),Toshimasa Onaya,M. J. Stevens,D. A. Greene	38
7	The Aetiology of Diabetic Neuropathy: the Combined Roles of Metabolic and Vascular Defects 1995 ·Diabetic Medicine ·M. J. Stevens,Eva L. Feldman,D. A. Greene	130
8	The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. 1994 ·Journal of Clinical Investigation ·Martin Stevens,J. Dananberg,Eva L. Feldman,S. A. Lattimer,Mikiko Kamijo,T. Thomas,Hiroko Shindo,Anders A. F. Sima,D. A. Greene	156
9	Transphosphatidylation of sugar alcohols and its implications for the pathogenesis of diabetic complications 1994 ·Diabetologia ·Jun Nakamura,S. A. Lattimer,D. A. Greene	4
10	Effects of glucose on sorbitol pathway activation, cellular redox, and metabolism of myo-inositol, phosphoinositide, and diacylglycerol in cultured human retinal pigment epithelial cells. 1994 ·Journal of Clinical Investigation ·T. Thomas,Francesca Porcellati,Koichi Kato,Martin J. Stevens,W. Richard Sherman,D. A. Greene	27
11	Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage 1993 ·Diabetes/Metabolism Reviews ·D. A. Greene,Anders A. F. Sima,M. J. Stevens,Eva L. Feldman,Paul D. Killen,Doriane Henry,T. Thomas,J. Dananberg,S. A. Lattimer	60
12	Overt Diabetic Neuropathy: Repair of Axo‐glial Dysjunction and Axonal Atrophy by Aldose Reductase Inhibition and its Correlation to Improvement in Nerve Conduction Velocity 1993 ·Diabetic Medicine ·Anders A. F. Sima,(unknown),Virgil Nathaniel,Vera Bril,(unknown),D. A. Greene	42
13	Effects of Aldose Reductase Inhibitors on the Progression of Nerve Damage 1993 ·Diabetic Medicine ·D. A. Greene,Anders A. F. Sima	14
14	Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells. 1993 ·Journal of Clinical Investigation ·Doriane Henry,Monte A. Del Monte,D. A. Greene,Paul D. Killen	53
15	Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells 1992 ·American Journal of Physiology-Endocrinology and Metabolism ·Jun Nakamura,Monte A. Del Monte,Donna S. Shewach,S. A. Lattimer,D. A. Greene	22
16	The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy 1992 ·Diabetologia ·Anders A. F. Sima,Marc B. Brown,(unknown),Subrata Chakrabarti,Charles Laudadio,D. A. Greene	27
17	Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications. 1991 ·PubMed ·Monte A. Del Monte,(unknown),(unknown),S. A. Lattimer,Jun Nakamura,Mary C. Brennan,D. A. Greene	43
18	Diabetic Neuropathy 1990 ·Annual Review of Medicine ·D. A. Greene,(unknown),Michael Pfeifer,James W. Albers	47
19	Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. 1990 ·Journal of Clinical Investigation ·Anders A. F. Sima,(unknown),(unknown),Subrata Chakrabarti,D. A. Greene	91
20	Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve 1987 ·Diabetologia ·Subrata Chakrabarti,Anders A. F. Sima,Takashi Nakajima,Soroku Yagihashi,D. A. Greene	86

About D. A. Greene

D. A. Greene is a scholar working on Physiology, Neurology and Cell Biology, having authored 64 papers that have together received 4.9k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (25 papers), Aldose Reductase and Taurine (19 papers) and Biochemical effects in animals (14 papers). The work is most often cited by research in Physiology (2.7k citations), Neurology (1.4k citations) and Clinical Biochemistry (498 citations). D. A. Greene has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include S. A. Lattimer, Anders A. F. Sima, Martin Stevens, Eva L. Feldman, Marc B. Brown, N. Canal, P. K. Thomas, A. I. Winegrad, Irina G. Obrosova and Carol Van Huysen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact